|
TRERF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.8018000000074E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.59690000012658E-07 |
| Normal-vs-Stage2 |
3.635800E-03 |
| Normal-vs-Stage3 |
2.853700E-02 |
| Normal-vs-Stage4 |
6.359200E-03 |
| Stage1-vs-Stage2 |
3.809600E-01 |
| Stage1-vs-Stage3 |
4.455800E-01 |
| Stage1-vs-Stage4 |
6.822600E-01 |
| Stage2-vs-Stage3 |
9.393800E-01 |
| Stage2-vs-Stage4 |
8.350600E-01 |
| Stage3-vs-Stage4 |
8.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16110000012182E-07 |
| Normal-vs-AfricanAmerican |
4.886100E-02 |
| Normal-vs-Asian |
5.729000E-01 |
| Caucasian-vs-AfricanAmerican |
5.741800E-02 |
| Caucasian-vs-Asian |
2.085600E-01 |
| AfricanAmerican-vs-Asian |
1.236230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89799999997342E-07 |
| Normal-vs-Female |
1.945820E-02 |
| Male-vs-Female |
6.641800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.463600E-03 |
| Normal-vs-Extreme_Weight |
1.38600000032518E-07 |
| Normal-vs-Obese |
1.55103999999184E-05 |
| Normal-vs-Extreme_Obese |
1.356740E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.068750E-01 |
| Normal_Weight-vs-Obese |
5.738000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.670570E-01 |
| Extreme_Weight-vs-Obese |
1.048830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.370800E-01 |
| Obese-vs-Extreme_Obese |
3.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.105200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.230400E-04 |
| Normal-vs-Age(61-80Yrs) |
6.44009999994921E-07 |
| Normal-vs-Age(81-100Yrs) |
6.15359999955878E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.532400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.488400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.055780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.922580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.040500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.443600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.53680000012113E-07 |
| Normal-VS-Type2 PRCC |
1.60064999999987E-05 |
| Normal-VS-KIRP CIMP |
4.115500E-03 |
| Normal-VS-Unclassified PRCC |
4.356100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.635800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.616600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.682400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.079200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.075600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.230600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.938500E-03 |
| Normal-vs-N1 |
4.980600E-01 |
| Normal-vs-N2 |
7.013400E-01 |
| N0-vs-N1 |
4.321800E-01 |
| N0-vs-N2 |
4.318000E-01 |
| N1-vs-N2 |
8.772800E-01 |
|
|
